PubMed:8376405 / 1188-1414 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T8","span":{"begin":0,"end":226},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Relative to wild type vWF, the mutant vWF exhibited markedly increased binding to platelets at low concentrations of ristocetin, confirming the association between the His-505--\u003eAsp substitution and the type IIB vWD phenotype."}

{"project":"DisGeNET","denotations":[{"id":"T4","span":{"begin":38,"end":41},"obj":"gene:7450"},{"id":"T5","span":{"begin":212,"end":215},"obj":"disease:C1282971"}],"relations":[{"id":"R3","pred":"associated_with","subj":"T4","obj":"T5"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Relative to wild type vWF, the mutant vWF exhibited markedly increased binding to platelets at low concentrations of ristocetin, confirming the association between the His-505--\u003eAsp substitution and the type IIB vWD phenotype."}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"8376405-7#22#25#gene7450","span":{"begin":22,"end":25},"obj":"gene7450"},{"id":"8376405-7#38#41#gene7450","span":{"begin":38,"end":41},"obj":"gene7450"},{"id":"8376405-7#212#215#diseaseC1282971","span":{"begin":212,"end":215},"obj":"diseaseC1282971"}],"relations":[{"id":"22#25#gene7450212#215#diseaseC1282971","pred":"associated_with","subj":"8376405-7#22#25#gene7450","obj":"8376405-7#212#215#diseaseC1282971"},{"id":"38#41#gene7450212#215#diseaseC1282971","pred":"associated_with","subj":"8376405-7#38#41#gene7450","obj":"8376405-7#212#215#diseaseC1282971"}],"text":"Relative to wild type vWF, the mutant vWF exhibited markedly increased binding to platelets at low concentrations of ristocetin, confirming the association between the His-505--\u003eAsp substitution and the type IIB vWD phenotype."}

{"project":"PubCasesORDO","denotations":[{"id":"AB4","span":{"begin":178,"end":181},"obj":"ORDO:63442"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"Relative to wild type vWF, the mutant vWF exhibited markedly increased binding to platelets at low concentrations of ristocetin, confirming the association between the His-505--\u003eAsp substitution and the type IIB vWD phenotype."}

{"project":"mondo_disease","denotations":[{"id":"T8","span":{"begin":212,"end":215},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0019565"}],"text":"Relative to wild type vWF, the mutant vWF exhibited markedly increased binding to platelets at low concentrations of ristocetin, confirming the association between the His-505--\u003eAsp substitution and the type IIB vWD phenotype."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T6","span":{"begin":82,"end":91},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CL_0000233"}],"text":"Relative to wild type vWF, the mutant vWF exhibited markedly increased binding to platelets at low concentrations of ristocetin, confirming the association between the His-505--\u003eAsp substitution and the type IIB vWD phenotype."}

{"project":"CL-cell","denotations":[{"id":"T5","span":{"begin":82,"end":91},"obj":"Cell"}],"attributes":[{"id":"A5","pred":"cl_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CL:0000233"}],"text":"Relative to wild type vWF, the mutant vWF exhibited markedly increased binding to platelets at low concentrations of ristocetin, confirming the association between the His-505--\u003eAsp substitution and the type IIB vWD phenotype."}